Glob J Health Sci. 2015 Jan 14;7(4):41351. doi: 10.5539/gjhs.v7n4p243.
Zendedel A1, Gholami M, Anbari K, Ghanadi K, Bachari EC, Azargon A.
1 School of medicine, Lorestan University of Medical Sciences, Khorramabad, Iran Correspondence: Alireza Azargon, School of medicine, Lorestan University of Medical Sciences, Khorramabad, Iran. E-mail: azargon.a at lums.ac.ir
100,000 IU monthly for 6 months in Iran (added to normal treatment)
Note: Iranians typically have low levels of vitamin D,
So even this little of vitamin D could provide some benefit
People with typical levels of vitamin D would probably need much more.
See also VitaminDWiki
- COPD Overview
- COPD getting worse is associated with very low vitamin D – March 2015
- 100000 IU vitamin D monthly helps COPD patients – 3 RCT (which is probably a duplicate for this study)
- Vitamin D treats COPD thru many pathways – March 2015
- COPD reduced by vitamin D taken once every 60 days – RCT Dec 2014
- Breathing category listing has
343 items along with related searches
- Search VitaminDWiki for COPD 338 items as of Dec 2014
- Vitamin D – monthly dosing was better than daily with Calcium – RCT Dec 2015
This study aimed to evaluate the effects of vitamin D intake on COPD exacerbation and FEV1 in the patients with severe and very severe COPD.
This double blind placebo control randomized clinical trial study was done in the Ashayer university hospital in Khorramabad in 2012. Eighty eight patients with severe and very severe COPD were randomly selected from those who recoursed to the internal medicine clinic of Ashayer hospital. They were randomly allocated to case and placebo group. The patients received routine treatment for COPD. Along with the routine treatment, placebo (case?) group received 100,000 IU of oral vitamin D per month, for 6 months. Data was analyzed using SPSS computer software, paired t-test, independent t-test, non parametric t-test and Pearson correlation coefficients.
In each group, there were 44 patients. After the intervention, there were significant differences in FEV1 and the number of COPD exacerbation between the case and control group patients. Also, after the study, in the case group, FEV1 was increased and the number of COPD exacerbation was decreased significantly.
Vitamin D intake decreased COPD exacerbation and improved FEV1 in the patients with severe and very severe COPD. It is suggested that baseline serum vitamin D levels will recorded in similar studies and the effect of vitamin D intake will evaluated regarding the baseline serum vitamin D levels.